(ALNT) Allient - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0193301092
Stock: Motor, Controller, Encoder, Servo, Drive
Total Rating 56
Risk 99
Buy Signal 1.54
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.36% |
| Yield on Cost 5y | 0.37% |
| Yield CAGR 5y | 3.39% |
| Payout Consistency | 46.5% |
| Payout Ratio | 7.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 50.5% |
| Relative Tail Risk | -8.06% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.13 |
| Alpha | 149.71 |
| Character TTM | |
|---|---|
| Beta | 1.159 |
| Beta Downside | 0.902 |
| Drawdowns 3y | |
|---|---|
| Max DD | 61.88% |
| CAGR/Max DD | 0.29 |
Description: ALNT Allient January 26, 2026
Allient Inc. (NASDAQ: ALNT) designs, manufactures, and sells precision-controlled motion components-including brushed and brushless DC motors, gearmotors, digital servo drives, optical encoders, and nano-precision positioning systems-to OEMs and end-users across vehicle, medical, aerospace & defense, and industrial markets worldwide. The firm operates through a direct sales force, authorized representatives, and distributors, and rebranded from Allied Motion Technologies in August 2023 after more than eight decades of history.
According to the company’s most recent Form 10-Q (Q2 2024), Allient generated $115.3 million in revenue, a 9 % year-over-year increase, with a gross margin of 38 % and free cash flow of $8.5 million. The order backlog rose to $210 million, up 12 % YoY, reflecting strong demand from the electric-vehicle (EV) drivetrain segment, which is expanding at an estimated 15 % CAGR globally. Defense spending in the United States grew 6 % in 2023, bolstering the aerospace & defense portion of Allient’s addressable market.
For a deeper quantitative dive, consider reviewing ValueRay’s analyst tools to assess how these trends may impact ALNT’s valuation.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 18.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 1.99 > 1.0 |
| NWC/Revenue: 34.71% < 20% (prev 34.55%; Δ 0.16% < -1%) |
| CFO/TA 0.09 > 3% & CFO 55.5m > Net Income 18.7m |
| Net Debt (174.1m) to EBITDA (71.1m): 2.45 < 3 |
| Current Ratio: 3.53 > 1.5 & < 3 |
| Outstanding Shares: last quarter (16.8m) vs 12m ago 1.05% < -2% |
| Gross Margin: 31.99% > 18% (prev 0.31%; Δ 3168 % > 0.5%) |
| Asset Turnover: 90.25% > 50% (prev 92.04%; Δ -1.79% > 0%) |
| Interest Coverage Ratio: 2.12 > 6 (EBITDA TTM 71.1m / Interest Expense TTM 21.4m) |
Altman Z'' 4.72
| A: 0.32 (Total Current Assets 258.1m - Total Current Liabilities 73.0m) / Total Assets 585.1m |
| B: 0.33 (Retained Earnings 191.2m / Total Assets 585.1m) |
| C: 0.08 (EBIT TTM 45.4m / Avg Total Assets 590.8m) |
| D: 1.01 (Book Value of Equity 294.2m / Total Liabilities 290.9m) |
| Altman-Z'' Score: 4.72 = AA |
Beneish M -3.03
| DSRI: 1.14 (Receivables 91.7m/82.5m, Revenue 533.1m/549.0m) |
| GMI: 0.98 (GM 31.99% / 31.28%) |
| AQI: 0.97 (AQ_t 0.41 / AQ_t-1 0.43) |
| SGI: 0.97 (Revenue 533.1m / 549.0m) |
| TATA: -0.06 (NI 18.7m - CFO 55.5m) / TA 585.1m) |
| Beneish M-Score: -3.03 (Cap -4..+1) = AA |
What is the price of ALNT shares?
As of February 07, 2026, the stock is trading at USD 65.74 with a total of 252,786 shares traded.
Over the past week, the price has changed by +7.75%, over one month by +14.17%, over three months by +30.20% and over the past year by +167.52%.
Over the past week, the price has changed by +7.75%, over one month by +14.17%, over three months by +30.20% and over the past year by +167.52%.
Is ALNT a buy, sell or hold?
Allient has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy ALNT.
- StrongBuy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ALNT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 53.4 | -18.8% |
| Analysts Target Price | 53.4 | -18.8% |
| ValueRay Target Price | 71.9 | 9.4% |
ALNT Fundamental Data Overview February 07, 2026
P/E Trailing = 55.4554
P/E Forward = 25.7069
P/S = 1.9739
P/B = 3.5538
Revenue TTM = 533.1m USD
EBIT TTM = 45.4m USD
EBITDA TTM = 71.1m USD
Long Term Debt = 182.5m USD (from longTermDebt, last quarter)
Short Term Debt = 5.84m USD (from shortTermDebt, last quarter)
Debt = 213.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 174.1m USD (from netDebt column, last quarter)
Enterprise Value = 1.23b USD (1.05b + Debt 213.6m - CCE 39.5m)
Interest Coverage Ratio = 2.12 (Ebit TTM 45.4m / Interest Expense TTM 21.4m)
EV/FCF = 25.75x (Enterprise Value 1.23b / FCF TTM 47.6m)
FCF Yield = 3.88% (FCF TTM 47.6m / Enterprise Value 1.23b)
FCF Margin = 8.94% (FCF TTM 47.6m / Revenue TTM 533.1m)
Net Margin = 3.50% (Net Income TTM 18.7m / Revenue TTM 533.1m)
Gross Margin = 31.99% ((Revenue TTM 533.1m - Cost of Revenue TTM 362.6m) / Revenue TTM)
Gross Margin QoQ = 33.29% (prev 30.97%)
Tobins Q-Ratio = 2.10 (Enterprise Value 1.23b / Total Assets 585.1m)
Interest Expense / Debt = 3.37% (Interest Expense 7.19m / Debt 213.6m)
Taxrate = 22.17% (1.84m / 8.32m)
NOPAT = 35.3m (EBIT 45.4m * (1 - 22.17%))
Current Ratio = 3.53 (Total Current Assets 258.1m / Total Current Liabilities 73.0m)
Debt / Equity = 0.73 (Debt 213.6m / totalStockholderEquity, last quarter 294.2m)
Debt / EBITDA = 2.45 (Net Debt 174.1m / EBITDA 71.1m)
Debt / FCF = 3.65 (Net Debt 174.1m / FCF TTM 47.6m)
Total Stockholder Equity = 280.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.16% (Net Income 18.7m / Total Assets 585.1m)
RoE = 6.66% (Net Income TTM 18.7m / Total Stockholder Equity 280.2m)
RoCE = 9.80% (EBIT 45.4m / Capital Employed (Equity 280.2m + L.T.Debt 182.5m))
RoIC = 7.32% (NOPAT 35.3m / Invested Capital 482.0m)
WACC = 8.91% (E(1.05b)/V(1.27b) * Re(10.19%) + D(213.6m)/V(1.27b) * Rd(3.37%) * (1-Tc(0.22)))
Discount Rate = 10.19% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.83%
[DCF Debug] Terminal Value 74.49% ; FCFF base≈43.3m ; Y1≈42.4m ; Y5≈43.2m
Fair Price DCF = 27.94 (EV 647.6m - Net Debt 174.1m = Equity 473.5m / Shares 16.9m; r=8.91% [WACC]; 5y FCF grow -2.88% → 2.90% )
EPS Correlation: -20.55 | EPS CAGR: -39.03% | SUE: -4.0 | # QB: 0
Revenue Correlation: 46.37 | Revenue CAGR: 10.08% | SUE: 1.22 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.58 | Chg30d=+0.030 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=2.54 | Chg30d=+0.049 | Revisions Net=+3 | Growth EPS=+18.3% | Growth Revenue=+5.4%
P/E Forward = 25.7069
P/S = 1.9739
P/B = 3.5538
Revenue TTM = 533.1m USD
EBIT TTM = 45.4m USD
EBITDA TTM = 71.1m USD
Long Term Debt = 182.5m USD (from longTermDebt, last quarter)
Short Term Debt = 5.84m USD (from shortTermDebt, last quarter)
Debt = 213.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 174.1m USD (from netDebt column, last quarter)
Enterprise Value = 1.23b USD (1.05b + Debt 213.6m - CCE 39.5m)
Interest Coverage Ratio = 2.12 (Ebit TTM 45.4m / Interest Expense TTM 21.4m)
EV/FCF = 25.75x (Enterprise Value 1.23b / FCF TTM 47.6m)
FCF Yield = 3.88% (FCF TTM 47.6m / Enterprise Value 1.23b)
FCF Margin = 8.94% (FCF TTM 47.6m / Revenue TTM 533.1m)
Net Margin = 3.50% (Net Income TTM 18.7m / Revenue TTM 533.1m)
Gross Margin = 31.99% ((Revenue TTM 533.1m - Cost of Revenue TTM 362.6m) / Revenue TTM)
Gross Margin QoQ = 33.29% (prev 30.97%)
Tobins Q-Ratio = 2.10 (Enterprise Value 1.23b / Total Assets 585.1m)
Interest Expense / Debt = 3.37% (Interest Expense 7.19m / Debt 213.6m)
Taxrate = 22.17% (1.84m / 8.32m)
NOPAT = 35.3m (EBIT 45.4m * (1 - 22.17%))
Current Ratio = 3.53 (Total Current Assets 258.1m / Total Current Liabilities 73.0m)
Debt / Equity = 0.73 (Debt 213.6m / totalStockholderEquity, last quarter 294.2m)
Debt / EBITDA = 2.45 (Net Debt 174.1m / EBITDA 71.1m)
Debt / FCF = 3.65 (Net Debt 174.1m / FCF TTM 47.6m)
Total Stockholder Equity = 280.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.16% (Net Income 18.7m / Total Assets 585.1m)
RoE = 6.66% (Net Income TTM 18.7m / Total Stockholder Equity 280.2m)
RoCE = 9.80% (EBIT 45.4m / Capital Employed (Equity 280.2m + L.T.Debt 182.5m))
RoIC = 7.32% (NOPAT 35.3m / Invested Capital 482.0m)
WACC = 8.91% (E(1.05b)/V(1.27b) * Re(10.19%) + D(213.6m)/V(1.27b) * Rd(3.37%) * (1-Tc(0.22)))
Discount Rate = 10.19% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.83%
[DCF Debug] Terminal Value 74.49% ; FCFF base≈43.3m ; Y1≈42.4m ; Y5≈43.2m
Fair Price DCF = 27.94 (EV 647.6m - Net Debt 174.1m = Equity 473.5m / Shares 16.9m; r=8.91% [WACC]; 5y FCF grow -2.88% → 2.90% )
EPS Correlation: -20.55 | EPS CAGR: -39.03% | SUE: -4.0 | # QB: 0
Revenue Correlation: 46.37 | Revenue CAGR: 10.08% | SUE: 1.22 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.58 | Chg30d=+0.030 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=2.54 | Chg30d=+0.049 | Revisions Net=+3 | Growth EPS=+18.3% | Growth Revenue=+5.4%